Gene Query: YIPF3

Dataset Description Geneva Score
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 40.74
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 22.32
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 20.48
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 20.47
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 19.12
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 18.51
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 18.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 18.1
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 18.1
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 15.96
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 15.96
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 15.31
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 14.77
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 14.52
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 14.5
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 14.37
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 13.99
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 13.96
A549 cells and MSR-A549 cells 13.96
Genome wide expression change by RNF168 knocking down in NEC cells 13.65
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 13.24
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 12.68
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 12.55
Expression profiling of etoposide-induced senescent cells 12.47
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 12.31
The human blood-nerve barrier transcriptome 12.1
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 12.02
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 12.01
Mitochondrial dsRNA triggers antiviral signalling in humans 11.97
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 11.93
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 11.93
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 11.87
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 11.82
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 11.75
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 11.66
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 11.64
RNA-sequencing of formalin fixed human primary melanoma tissue 11.47
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 11.43
MYCi361 regulates MYC target genes 11.4
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 11.4
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 11.4
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 11.29
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.23
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 10.99
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 10.97
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 10.96
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 10.92
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 10.91
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 10.9
Differential analysis of gene regulation at transcript resolution by RNA-Seq 10.9
Differetially expressed genes after hTR overexpression in U2OS cells 10.7
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 10.63
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 10.63
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 10.56
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 10.53
RNA-seq differential expression studies: more sequence, or more replication? 10.52
Transcriptome of diurnal human blood neutrophils 10.15
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 10.09
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 9.97
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 9.62
Nucleoporin-mediated regulation of cell identity genes 9.32
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 9.22
Expression profiling of MCF-7 cells with treatment of TCDD 9.22
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 9.21
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 9.21
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 9.16
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 9.0
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 8.85
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.83
Ebola virus (EBOV) infection of ARPE-19 cells 8.82
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 8.64
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.53
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.51
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 8.47
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 8.41
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.41
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 8.37
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.26
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 8.23
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.2
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.17
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 8.15
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 8.15
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.15
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.15
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 8.14
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.14
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.14
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 8.13
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.1
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 8.04
The role of FAM46C in myeloma cells 7.97
The role of FAM46C in myeloma cells [sequencing] 7.97
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.97
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 7.96
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 7.95
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 7.89
Human neutrophil genome during PMA- and E. coli encounter-induced activation 7.89
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 7.87
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 7.86
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.83
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 7.83
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 7.82
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.77
RNA-Seq in neutrophils from Antiphospholipid Syndrome 7.72
Morphological and molecular characterization of human dermal lymphatic collectors 7.7
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 7.66
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.63
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 7.62
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.56
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.5
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 7.46
LncRNA-GAS5 negative regulation of YAP-target genes expression 7.45
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.37
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 7.26
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 7.25
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 7.23
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 7.23
Biological effect of chronic mistranslation in mammalian cells 7.21
Accurate annotation of human protein-coding small open reading frames 7.2
The landscape of alternative splicing in aggressive prostate cancers 7.2
Gene expression analysis of the impact of TDP-43 knockout in human cells. 7.15
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.1
T47D RNA-seq and ChrRNA-seq data 7.1
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 7.1
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 7.1
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 7.08
RNA-seq analysis of AML cells in response to ASLAN003 7.03
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 6.99
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 6.93
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 6.92
Impact of dieldrin on transcription in Jurkat T cells 6.91
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 6.9
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.88
Modeling Familial Cancer with iPSC Approaches 6.85
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 6.8
METTL3 promotes translation in human cancer cells 6.77
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.73
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 6.72
Human Treg NaCl stimulation 6.65
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 6.63
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 6.63
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 6.61
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 6.61
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 6.58
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.58
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 6.56
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 6.48
Splicing and epigenetic factors jointly regulate epidermal differentiation 6.47
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 6.47
RNA-seq of IL-4 stimulated human keratinocytes 6.45
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.42
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.42
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 6.4
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.38
RNA m5C Methylation in breast cancer using MeRIP-Seq 6.35
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 6.31
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 6.26
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 6.25
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 6.23
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.21
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.2
N6-methyladenine DNA Modification in Glioblastoma 6.2
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.14
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 6.12
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 6.12
Mutational landscape of splicing genes and functional consequences across 33 cancer types 6.11
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.11
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.08
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.08
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.05
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.03
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.03
TGF-β regulation of miRNA expression in pancreatic cancer 6.03
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 6.02
Gene expression profiling of human and murine in vitro muscle differentiation 6.01
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 6.0
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.98
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 5.96
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 5.95
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 5.95
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.93
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 5.92
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 5.91
High-throughput sequencing of pluripotent cells 5.91
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.89
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.89
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 5.82
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.79
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.79
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.79
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.79
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 5.78
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.78
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 5.78
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 5.77
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 5.75
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 5.75
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.75
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 5.73
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 5.73
Microprocessor mediates transcription termination in long noncoding microRNA genes 5.7
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.69
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.67
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 5.67
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.67
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 5.65
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.64
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.62
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 5.61
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 5.61
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 5.55
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.51
RNA-seq of YB5 cells treated with Proscillaridin A 5.48
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 5.4
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 5.39
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.39
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.39
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 5.36
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 5.35
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 5.35
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.35
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.35
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 5.33
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 5.31
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 5.31
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.29
Patient-derived xenograft platform for metastatic melanoma 5.25
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 5.23
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 5.22
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 5.22
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.14
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.14
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 5.13
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 5.12
RNA Seq of HMVEC under hypoxia 5.12
Silencing SPIB in attached and floating state of H1703 lung cancer cells 5.09
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 5.03
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.03
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.01
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.01
scRNASeq analysis of cycling cardiomyocytes 4.96
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 4.95
RNA-sequencing in immortalized human mammary epithelial cells 4.95
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.91
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 4.86
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.86
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 4.85
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.84
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 4.81
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 4.81
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.81
Illumina Total RNA-seq in HeLa 4.81
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 4.8
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.77
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.77
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 4.77
Postnatal lipids drive hepatocyte maturation 4.75
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 4.73
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 4.72
Triple vectors expand AAV transfer capacity in the retina 4.7
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.7
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 4.67
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 4.65
RNA-seq analysis of the human fetal kidney. 4.64
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.59
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.54
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 4.53
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 4.53
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 4.52
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 4.5
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.39
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.39
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.38
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.38
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.35
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.28
SLIGRL-induced gene expression changes in NHEK cells 4.26
Activity-dependent transcriptional changes in human neurons 4.25
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.23
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.21
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 4.18
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.18
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 4.14
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.12
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 4.11
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.09
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 4.07
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.05
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.05
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.03
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.03
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.98
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.98
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.94
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 3.92
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 3.9
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.89
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.89
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.88
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.86
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 3.8
Transciptomic profiling of human fetal lung samples 3.73
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.73
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.73
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.73
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.73
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.73
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.66
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.66
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 3.64
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 3.64
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 3.63
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.63
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.62
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.62
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 3.6
Expression by CD133+ cells isolated from the adult human exocrine pancreas 3.6
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.6
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.56
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.56
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.54
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.54
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 3.52
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.51
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 3.46
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.45
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 3.43
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.43
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.41
Retinoic acid suppresses MYB in adenoid cystic carcinoma 3.38
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 3.38
Hepatitis C virus functionally sequesters miR-122 3.38
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.38
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.38
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.38
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.37
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.37
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 3.37
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 3.37
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 3.34
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.34
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.32
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.32
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.29
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 3.28
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 3.28
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 3.25
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 3.22
mRNA expression in human DAOY cells 3.07
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 3.06
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.0
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 2.94
Loss of CREBBP results in gene expression repression in lymphoma cells 2.91
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.91
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.91
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.88
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.87
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.86
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.83
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.82
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.82
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.78
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.74
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.72
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.67
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.63
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.63
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 2.6
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.56
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.56
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 2.55
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.5
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.49
DRB/GRO-Seq -/+ UV 2.49
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 2.46
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.41
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.39
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.36
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.36
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 2.31
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.3
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.28
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.28
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.26
Effect of from Human Umbilical Vein Endothelial Cells 2.24
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 2.22
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 2.21
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.16
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.16
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.15
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.15
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.15
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.14
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.14
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.11
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.01
An optimization system for isolating and sequencing of single human colon cancer cells 1.96
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 1.92
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.91
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.86
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.83
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 1.82
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 1.82
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.79
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.79
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.79
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 1.77
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.74
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.66
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.65
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.64
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.58
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.57
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.55
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.53
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.48
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.46
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.44
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.44
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.43
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.41
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.36
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.31
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.31
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.29
Measure transcript integrity using RNA-seq data 1.28
Interaction between mitoNEET and NAF-1 in cancer cells 1.25
High-resolution comparative analysis of great ape genomes 1.21
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.16
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.14
Iron response of HepG2 cells 1.13
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.13
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.1
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.08
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.08
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.98
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.95
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.95
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.87
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.87
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.84
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.83
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.8
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.8
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.8
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.8
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.8
Gene expression alterations of pancreatic intraepithlial neoplasia 0.79
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.74
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.73
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.72
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 0.72
Active translatome profiling with RiboLace in MCF7 cells 0.72
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 0.72
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.71
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.71
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.69
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.65
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.65
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.63
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.62
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.62
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.6
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.59
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.58
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.58
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.58
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.57
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.52
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.5
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.48
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.43
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.38
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.33
Downregulation of LATS kinases alters p53 to promote cell migration 0.33
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.33
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.31
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.3
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.27
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.26
Gene expression analysis of human adenomas. 0.26
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.25
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.25
Ribosomal protein RPL26 is the principal target of UFMylation 0.23
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.21
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.18
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.17
The role of the Calcium-Sensing receptor in colorectal cancer 0.12
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.12
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.12
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.09
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.05
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.05
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.04
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.04
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.02
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.01
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.01
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation